A new mutation of the MEN1 gene in an italian kindred with multiple endocrine neoplasia type 1

in European Journal of Endocrinology
Authors:
F CetaniDipartimento di Endocrinologia e Metabolismo, Ortopedia e Traumatologia, Medicina del Lavoro, Universita di Pisa, Pisa, Italy.

Search for other papers by F Cetani in
Current site
Google Scholar
PubMed
Close
,
E PardiDipartimento di Endocrinologia e Metabolismo, Ortopedia e Traumatologia, Medicina del Lavoro, Universita di Pisa, Pisa, Italy.

Search for other papers by E Pardi in
Current site
Google Scholar
PubMed
Close
,
L CianferottiDipartimento di Endocrinologia e Metabolismo, Ortopedia e Traumatologia, Medicina del Lavoro, Universita di Pisa, Pisa, Italy.

Search for other papers by L Cianferotti in
Current site
Google Scholar
PubMed
Close
,
E VignaliDipartimento di Endocrinologia e Metabolismo, Ortopedia e Traumatologia, Medicina del Lavoro, Universita di Pisa, Pisa, Italy.

Search for other papers by E Vignali in
Current site
Google Scholar
PubMed
Close
,
A PiconeDipartimento di Endocrinologia e Metabolismo, Ortopedia e Traumatologia, Medicina del Lavoro, Universita di Pisa, Pisa, Italy.

Search for other papers by A Picone in
Current site
Google Scholar
PubMed
Close
,
P MiccoliDipartimento di Endocrinologia e Metabolismo, Ortopedia e Traumatologia, Medicina del Lavoro, Universita di Pisa, Pisa, Italy.

Search for other papers by P Miccoli in
Current site
Google Scholar
PubMed
Close
,
A PincheraDipartimento di Endocrinologia e Metabolismo, Ortopedia e Traumatologia, Medicina del Lavoro, Universita di Pisa, Pisa, Italy.

Search for other papers by A Pinchera in
Current site
Google Scholar
PubMed
Close
, and
C MarcocciDipartimento di Endocrinologia e Metabolismo, Ortopedia e Traumatologia, Medicina del Lavoro, Universita di Pisa, Pisa, Italy.

Search for other papers by C Marcocci in
Current site
Google Scholar
PubMed
Close
View More View Less
Free access

OBJECTIVE: To report a new mutation of the multiple endocrine neoplasia type 1 (MEN1) gene in an Italian kindred. DESIGN: The study included the female proband, aged 50 years, affected by primary hyperparathyroidism, insulinoma and prolactinoma, and ten relatives. Blood samples were obtained for biochemical and genetic analyses. Clinical screening tests included serum glucose, ionized calcium, intact parathyroid hormone, GH, insulin and prolactin. The coding sequence, including nine coding exons and 16 splice sites, was amplified by PCR and directly sequenced. RESULTS: Two additional cases of primary hyperparathyroidism were identified among the paternal family members. The sequence analysis showed a heterozygous T to C transition at codon 444 in exon 9, resulting in a leucine to proline substitution (L444P) in the patient and in the two paternal family members with primary hyperparathyroidism. The L444P amino acid change was absent in 50 normal subjects. The mutation determined the loss of a BlnI restriction site of the wild-type sequence and the creation of a new restriction EcoRII site. The patient, but not her paternal affected relatives, also had a common heterozygous polymorphism (D418D) in exon 9. CONCLUSIONS: A new MEN1 mutation (L444P) in exon 9 has been identified; this substitution caused the loss of a BlnI restriction site and the creation of a new EcoRII site.

 

  • Collapse
  • Expand

     European Society of Endocrinology